We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Daily Statin Trial for People With HIV Halted Early for Clear Benefit.
- Authors
Harris, Emily
- Abstract
Adverse drug events among study participants, who were taking antiretroviral therapy, were no higher than among the general population receiving statins. Medical News in Brief People with HIV and a low to moderate traditional risk of cardiovascular disease who took a daily 4-mg dose of pitavastatin reduced their risk of major adverse cardiovascular events by 35% relative to a placebo group, according to interim results from a randomized clinical trial that enrolled nearly 7769 participants across 12 countries.
- Subjects
STATINS (Cardiovascular agents); HIV-positive persons; MAJOR adverse cardiovascular events
- Publication
JAMA: Journal of the American Medical Association, 2023, Vol 329, Issue 19, p1633
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.2023.6619